Bill Text: TX SB1606 | 2017-2018 | 85th Legislature | Introduced


Bill Title: Relating to the dispensing of aesthetic pharmaceuticals by physicians; authorizing fees.

Spectrum: Partisan Bill (Republican 1-0)

Status: (Introduced - Dead) 2017-03-21 - Referred to Health & Human Services [SB1606 Detail]

Download: Texas-2017-SB1606-Introduced.html
  85R7025 BEE-F
 
  By: Creighton S.B. No. 1606
 
 
 
A BILL TO BE ENTITLED
 
AN ACT
  relating to the dispensing of aesthetic pharmaceuticals by
  physicians; authorizing fees.
         BE IT ENACTED BY THE LEGISLATURE OF THE STATE OF TEXAS:
         SECTION 1.  Section 157.002(f), Occupations Code, is amended
  to read as follows:
         (f)  Subsections (b) and (c) do not authorize a physician or
  a person acting under the supervision of a physician to keep a
  pharmacy, advertised or otherwise, for the retail sale of dangerous
  drugs, other than as authorized under Section 158.003 and
  Subchapter B, Chapter 158, without complying with the applicable
  laws relating to the dangerous drugs.
         SECTION 2.  Chapter 158, Occupations Code, is amended by
  designating Sections 158.001, 158.002, and 158.003, Occupations
  Code, as Subchapter A, Chapter 158, Occupations Code, and adding a
  subchapter heading to read as follows:
  SUBCHAPTER A.  PROVISION OF DRUGS AND SUPPLIES UNDER CERTAIN
  CIRCUMSTANCES
         SECTION 3.  Chapter 158, Occupations Code, is amended by
  adding Subchapter B to read as follows:
  SUBCHAPTER B.  DISPENSING OF AESTHETIC PHARMACEUTICALS
         Sec. 158.051.  DEFINITION.  In this subchapter, "aesthetic
  pharmaceutical" means:
               (1)  a drug listed in the aesthetic pharmaceutical
  group under Section 158.055; or
               (2)  a drug that:
                     (A)  is not a controlled substance;
                     (B)  requires a prescription for dispensation;
                     (C)  is legally marketed under 21 U.S.C. Section
  355, if it is a new drug subject to that section; and
                     (D)  is prescribed for the enhancement of an
  individual's appearance.
         Sec. 158.052.  DISPENSING PERMITTED; FEE AUTHORIZED. A
  physician may dispense to the physician's patients an aesthetic
  pharmaceutical in excess of the patient's immediate needs without
  obtaining a license under Chapter 558. The physician may charge a
  fee for dispensing the pharmaceutical.
         Sec. 158.053.  NOTICE; LABELING; RECORDKEEPING. (a)  Before
  dispensing an aesthetic pharmaceutical to a patient, a physician
  must inform the patient that the prescription for the
  pharmaceutical may be filled at a pharmacy, if available at a
  pharmacy, or dispensed in the physician's office.
         (b)  Each state and federal labeling and recordkeeping
  requirement applicable to an aesthetic pharmaceutical must be
  followed and documented. A record maintained under this section
  must be accessible as provided under state and federal law.
         Sec. 158.054.  RULES; FEES. The board shall adopt rules to
  govern the packaging, labeling, and dispensing of aesthetic
  pharmaceuticals under this subchapter. The board shall adopt
  reasonable fees as necessary to implement this subchapter. A fee
  adopted under this section may not exceed a fee adopted under
  Section 554.006 for authorizing a pharmacist to dispense
  pharmaceuticals.
         Sec. 158.055.  AESTHETIC PHARMACEUTICAL GROUP. The
  aesthetic pharmaceutical group consists of:
               (1)  bimatoprost;
               (2)  hydroquinone;
               (3)  tretinoin;
               (4)  metronidazole;
               (5)  tazarotene;
               (6)  eflornithine;
               (7)  dapsone;
               (8)  salicylic acid;
               (9)  topical medications containing urea;
               (10)  mequinol; and
               (11)  resorcinol.
         SECTION 4.  Section 563.051(d), Occupations Code, is amended
  to read as follows:
         (d)  This section does not authorize a physician or a person
  acting under the supervision of a physician to keep a pharmacy,
  advertised or otherwise, for the retail sale of dangerous drugs,
  other than as authorized under Section 158.003 and Subchapter B,
  Chapter 158, without complying with the applicable laws relating to
  the dangerous drugs.
         SECTION 5.  The Texas Medical Board shall adopt rules for the
  implementation of Subchapter B, Chapter 158, Occupations Code, as
  added by this Act, not later than January 1, 2018.
         SECTION 6.  (a)  Except as provided by Subsection (b) of this
  section, this Act takes effect immediately if it receives a vote of
  two-thirds of all the members elected to each house, as provided by
  Section 39, Article III, Texas Constitution. If this Act does not
  receive the vote necessary for immediate effect, this Act takes
  effect September 1, 2017.
         (b)  Sections 158.052 and 158.053, Occupations Code, as
  added by this Act, take effect July 1, 2018.
feedback